Aflac is overvalued at 16x while the whole life sector trades 4-9x, hence a sell.
Lincoln at 4.6x earnings is mispriced after de-risking its toxic SGUL book; rerate higher.
CoreBridge and Equitable have de-risked but underuse a free ROI home run: aggressive buyback.
Merged Equitable leans into AB growth and efficiency, not riskier spread, so the fee-heavier mix re-rates EQH higher.